Industry

DUBLIN–(BUSINESS WIRE)–The “Corporate Wellness Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Corporate Wellness Market is projected to reach USD 81,715.37 million by 2027 from USD 42,138.66 million in 2021, at a CAGR 11.67% during the forecast period. Market Statistics: The Americas Corporate Wellness Market size … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Progesterone Receptor (PR) Antagonist development. The report provides detailed coverage of the pipeline landscape for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel (CMP) Testing Market Analysis by Disease Type (Diabetes, Kidney Disease, Liver Disease), by End User (Point Of Contact (PoC), Laboratories), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global comprehensive metabolic panel (CMP) testing market size is estimated to be USD 12.5 billion … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global interventional neurology market size is estimated to be USD 2,702.4 … [Read more…]

Agenda Includes Improving the Participant Experience, Post-Pandemic Employee Benefit Perceptions, and Diversity, Equity, and Inclusion Initiatives WASHINGTON–(BUSINESS WIRE)–ECFC, the leading nonprofit organization promoting choice in consumer-driven benefit solutions, will hold its 35th Annual Symposium on August 3-5 to educate benefits industry professionals on evolving healthcare trends in a post-pandemic healthcare environment. The 35th Annual Symposium … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Brain Cancer Treatment Drugs Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that ALBRIOZA™ (sodium phenylbutyrate and ursodoxicoltaurine) is now commercially available in Canada for people living with amyotrophic lateral sclerosis (ALS). ALBRIOZA (also known as AMX0035) is an oral fixed-dose combination therapy that may reduce neuronal cell death as a stand-alone therapy or … [Read more…]

Expanding access to affordable oncology medicines LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today it has introduced Thiotepa for Injection, USP, in the United States. Thiotepa, a generic equivalent to Tepadina®, is the newest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. Fresenius Kabi Thiotepa for Injection, USP is available … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance Auditing and Inspections Course” training has been added to ResearchAndMarkets.com’s offering. This seminar will also focus on the risk base approaches in response to COVID – 19 including recent legislation governing the conduct of these activities. PV Audit Strategy Planning course will provide an overview of the European Medicines Agency’s (EMA) … [Read more…]

–– Enrollment of PNH Patients Expected to Begin this Summer — SEATTLE–(BUSINESS WIRE)–Omeros Corporation today announced that OMS906 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). OMS906 targets mannan-binding lectin-associated serine protease-3 (MASP-3), the key activator of the alternative pathway of the … [Read more…]